Abstract
We report molecular analysis of thiamin-responsive pyruvate dehydrogenase complex (PDHC) deficiency in a patient with an X-linked form of Leigh syndrome. PDHC activity in cultured lymphoblastoid cells of this patient and his asymptomatic mother were normal in the presence of a high thiamin pyrophosphate (TPP) concentration (0.4 mmol/L). However, in the presence of a low concentration (1 X 10-4 mmol/L) of TPP, the activity was significantly decreased, indicating that PDHC deficiency in this patient was due to decreased affinity of PDHC for TPP. The patient's older brother also was diagnosed as PDHC deficiency with Leigh syndrome, suggesting that PDHC deficiency in these two brothers was not a de novo mutation. Sequencing of the X-linked PDHC E1 α subunit revealed a C → G point mutation at nucleotide 787, resulting in a substitution of glycine for arginine 263. Restriction enzyme analysis of the E1α gene revealed that the mother was a heterozygote, indicating that thiamin-responsive PDHC deficiency associated with Leigh syndrome due to this mutation is transmitted by X-linked inheritance.
Similar content being viewed by others
REFERENCES
Benke P, Parker J, Lubs ML, Benkendorf J, Feuer AE (1982) X-linked Leigh's syndrome. Hum Genet 62: 52–59.
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.
Brown RM, Dahl HHM, Brown GK (1989) X-chromosome localization of the functional gene for the E1α subunit of the human pyruvate dehydrogenase complex. Genomics 4: 174–181.
Chun K, MacKay N, Petrova-Benedict R, Robinson BH (1993) Mutations in the X-linked E1α subunit of pyruvate dehydrogenase leading to deficiency of the pyruvate dehydrogenase complex. Hum Mol Genet 2: 449–454.
Chun K, MacKay N, Petrova-Benedict R, et al (1995) Mutations in the X-linked E1α subunit of pyruvate dehydrogenase: exon skipping, insertion of duplicate sequence, and missense mutations leading to deficiency of the pyruvate dehydrogenase complex. Am J Hum Genet 56, 558–569.
Dahl HHM, Brown GK, Brown RM, et al (1992) Mutations and polymorphisms in the pyruvate dehydrogenase E1α gene. Hum Mutat 1: 97–102.
De Vivo DC, Haymond MW, Obert KA, Nelson JS, Pagliara AS (1979) Defective activation of the pyruvate dehydrogenase complex in subacute necrotizing encephalomyelopathy (Leigh disease). Ann Neurol 6: 483–494.
Fujii T, Ito M, Okuno T, Mutoh K, Nishikomori R, Mikawa H (1990) Complex I (reduced nicotinamide-adenine dinucleotide-coenzyme Q reductase) deficiency in two patients with probable Leigh syndrome. J Pediatr 116: 84–87.
Huq AHMM, Ito M, Naito E, Saijo T, Takeda E, Kuroda Y (1991) Demonstration of an unstable variant of pyruvate dehydrogenase protein (E1) in cultured fibroblasts from a patient with congenital lactic acidemia. Pediatr Res 30: 11–14.
Ito M, Huq AHMM, Naito E, Saijo T, Takeda E, Kuroda Y (1992) Mutation of E1α gene in a female patient with pyruvate dehydrogenase deficiency due to rapid degradation of E1 protein. J Inher Metab Dis 15: 848–856.
Kerr DS, Berry SA, Lusk MM, Ho L, Patel MS (1988) A deficiency of both subunits of pyruvate dehydrogenase which is not expressed in fibroblasts. Pediatr Res 24: 95–100.
Koch TK, Yee HC, Hutchinson HT, Berg BO (1986) Magnetic resonance imaging in subacute necrotizing encephalomyelopathy (Leigh's Disease). Ann Neurol 19: 605–607.
Krageloh-Mann I, Grodd W, Niemann G, Haas G, Ruitenbeek W (1992) Assessment and therapy monitoring of Leigh disease by MRI and proton spectroscopy. Pediatr Neurol 8: 60–64.
Leigh D (1951) Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14: 216–221.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275.
Mascher H, Kikuta C (1993) High-performance liquid chromatographic determination of total thiamine in human plasma for oral bioavailability studies. J Pharm Sci 82: 56–59.
Matthews PM, Marchington DR, Squier M, Land J, Brown RM, Brown GK (1993) Molecular genetic characterization of an X-linked form of Leigh's syndrome. Ann Neurol 33: 652–655.
Naito E, Ito M, Takeda E, Yokota I, Yoshijima S, Kuroda Y (1994a) Molecular analysis of abnormal pyruvate dehydrogenase in a patient with thiamine-responsive congenital lactic acidemia. Pediatr Res 36: 340–346.
Naito E, Ito M, Yokota I, et al (1994b) Molecular analysis of abnormal pyruvate dehydrogenase in two patients with thiamine-responsive congenital lactic acidemia. Muscle Nerve Suppl. 1: S128.
Olson S, Song BJ, Huh TL, Chi YT, Veech RL, McBride OW (1990) Three genes for enzymes of the pyruvate dehydrogenase complex map to human chromosomes 3, 7, and X. Am J Hum Genet 46: 340–349.
Robinson BH, Chun K (1993) The relation between transketolase, yeast pyruvate decarboxylase and pyruvate dehydrogenase of the pyruvate dehydrogenase complex. FEBS Lett 328: 99–102.
Toshima K, Kuroda Y, Hashimoto T, et al (1982) Enzymologic studies and therapy of Leigh's disease associated with pyruvate decarboxylase deficiency. Pediatr Res 16: 430–435.
Van Erven PMM, Cillessen JPM, Eekhoff EMW, et al (1987) Leigh syndrome, a mitochondrial encephalo(myo)pathy. Clin Neurol Neurosurg 89: 217–230.
Wexler ID, Hemalatha SG, Liu TC, Berry SA, Kerr DS, Patel MS (1992) A mutation in the E1α subunit of pyruvate dehydrogenase associated with variable expression of pyruvate dehydrogenase complex deficiency. Pediatr Res 32: 169–174.
Willems JL, Monnens LA, Trijbels LMF (1977) Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics 60: 850–857.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Naito, E., Ito, M., Yokota, I. et al. Biochemical and molecular analysis of an X-linked case of Leigh syndrome associated with thiamin-responsive pyruvate dehydrogenase deficiency. J Inherit Metab Dis 20, 539–548 (1997). https://doi.org/10.1023/A:1005305614374
Issue Date:
DOI: https://doi.org/10.1023/A:1005305614374